The coming of age of engineered multivalent antibodies

Drug Discovery Today
Natalia Nuñez-PradoLuis Alvarez-Vallina

Abstract

The development of monoclonal antibody (mAb) technology has had a profound impact on medicine. The therapeutic use of first-generation mAb achieved considerable success in the treatment of major diseases, including cancer, inflammation, autoimmune, cardiovascular, and infectious diseases. Next-generation antibodies have been engineered to further increase potency, improve the safety profile and acquire non-natural properties, and constitute a thriving area of mAb research and development. Currently, a variety of alternative antibody formats with modified architectures have been generated and are moving fast into the clinic. In fact, the bispecific antibody blinatumomab was the first in its class to be approved by the US Food and Drug Administration (FDA) as recently as December 2014. Here, we outline the fundamental strategies used for designing the next generation of therapeutic antibodies, as well as the most relevant results obtained in preclinical studies and clinical trials.

References

Nov 1, 1994·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·K P O'BoyleK Bhargava
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·M MackP Kufer
Jul 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P HolligerG Winter
Jun 1, 1997·Protein Engineering·E LiO Burrone
Oct 29, 2000·The Journal of Biological Chemistry·K Els ConrathS Muyldermans
Feb 27, 2001·Journal of Immunological Methods·A TodorovskaP J Hudson
Aug 23, 2003·Blood·Laura BorsiLuciano Zardi
Sep 13, 2003·Journal of Immunological Methods·Dan LuZhenping Zhu
Nov 25, 2003·Nature Biotechnology·Sergey M DeyevAndreas Plückthun
Apr 23, 2004·Trends in Immunology·Laura SanzLuis Alvarez-Vallina
May 27, 2005·Acta Pharmacologica Sinica·Laura SanzLuis Alvarez-Vallina
Jun 2, 2005·Nature Reviews. Cancer·Dario Neri, Roy Bicknell
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jürgen GrünbergP August Schubiger
Sep 10, 2005·Nature Biotechnology·Philipp Holliger, Peter J Hudson
Oct 11, 2005·Drug Discovery Today·Evelyn WolfPatrick A Baeuerle
Feb 16, 2006·International Journal of Cancer. Journal International Du Cancer·Víctor J Sánchez-Arévalo LoboLuis Alvarez-Vallina
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Edmund A RossiChien-Hsing Chang
Apr 28, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Enrica BalzaLaura Borsi
Dec 5, 2006·Journal of Immunological Methods·Emily StoneJianbing Zhang
Aug 19, 2007·Nature Reviews. Immunology·Derry C Roopenian, Shreeram Akilesh
Jul 19, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chia-Yu FanMin-Yuan Chou
Aug 12, 2008·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Sergey M Deyev, Ekaterina N Lebedenko
Oct 2, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Angel M CuestaLuis Alvarez-Vallina
Nov 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey V LeytonAnna M Wu
Dec 17, 2008·Current Pharmaceutical Biotechnology·Alain BeckNathalie Corvaïa
May 23, 2009·British Journal of Pharmacology·Patrick ChamesDaniel Baty
Jun 6, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Roland E Kontermann
Aug 20, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Tove OlafsenAnna M Wu
Apr 1, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Eric J LepinAnna M Wu

❮ Previous
Next ❯

Citations

Nov 26, 2015·Nature Reviews. Clinical Oncology·Mark J SmythMichele W L Teng
Jan 14, 2016·MAbs·Songmao ZhengWeirong Wang
Dec 23, 2015·Journal of Hematology & Oncology·Gaowei FanJinming Li
Mar 21, 2016·Current Opinion in Immunology·Davide Corti, Jeffrey D Kearns
Apr 17, 2016·Current Opinion in Immunology·Janine Schuurman, Paul Whi Parren
Aug 5, 2015·AMB Express·Ana Blanco-ToribioLuis Álvarez-Vallina
May 10, 2016·Analytical Biochemistry·Shima Moradi-KalbolandiMohammad Ali Shokrgozar
Feb 12, 2017·Frontiers in Immunology·Hongyan LiuDonghui Wu
Oct 26, 2018·Organic & Biomolecular Chemistry·Berlin ZangLingyun Jia
Nov 2, 2018·Biochemical Society Transactions·Obinna C UbahCaroline J Barelle
Feb 8, 2019·Current Pharmaceutical Design·Huanbo TanPeijian Zou
Aug 6, 2019·Scandinavian Journal of Immunology·Jacek Hawiger, Jozef Zienkiewicz
Jan 18, 2020·International Journal of Molecular Sciences·Rebecca C AbbottMisty R Jenkins
Sep 2, 2017·Biotechnology Journal·Beate BeyerNico Lingg
Apr 11, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Keith J Arlotta, Shawn C Owen
Jun 6, 2018·Cancer Immunology, Immunotherapy : CII·Kasper MølgaardLuis Alvarez-Vallina
Nov 30, 2019·Proceedings of the National Academy of Sciences of the United States of America·Wesley J ErringtonCasim A Sarkar
Nov 19, 2017·The Journal of Biological Chemistry·Dennis R GouletMark L Chiu
Feb 1, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zhaoyi LiXian-Da Yang
Dec 26, 2015·Antibodies·Joanie Del BanoBrigitte Kerfelec
Sep 10, 2020·Frontiers in Immunology·Belén BlancoLuis Alvarez-Vallina
Sep 22, 2017·Journal of Hematology & Oncology·Shengnan YuKongming Wu
Apr 30, 2017·Chemical Science·Daniel A RichardsVijay Chudasama
Nov 6, 2018·Frontiers in Immunology·Mathieu DondelingerMarylène S Vandevenne
Dec 2, 2020·International Journal of Molecular Sciences·Atsushi KuwaharaRyutaro Asano
Mar 25, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James E Talmadge
Apr 3, 2021·Science·Robby DivineDavid Baker
Oct 27, 2018·ACS Applied Materials & Interfaces·Miyeon LeeTaejoon Kang
Jul 24, 2020·Bioconjugate Chemistry·Martine DarwishCraig Blanchette
Sep 8, 2021·Cancer Cell International·Reza MahmoudiMohammad Rahmati
Jun 11, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Belén BlancoLuis Alvarez-Vallina

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.